A Clinical Trial of the Safety and Anti-Tumor Activity of AB-201 in Subjects With Advanced HER2+ Solid Tumors
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Gastric Cancer|Gastroesophageal Junction Adenocarcinoma
Interventions: DRUG: AB-201|DRUG: Cyclophosphamide|DRUG: Fludarabine
Sponsor: Artiva Biotherapeutics, Inc.